Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

Competition versus coalition
01 September, 2020
In the most high-stakes cases, the right choice in comparator sourcing...
> read more

A matter of life and death 01 September, 2020 Clinical trial supply professionals have long understood the importance of remaining agile in keeping up with increasingly complex trial demands. Now, with Covid-19,...

Open questions 01 September, 2020 It’s been a slow, piecemeal process, but in recent years regulators have begun to develop a framework for using real-world evidence (RWE), shining a light on the important role it...

Ghost writer 01 September, 2020 Medical writers have tried just about every technique to speed up the process of producing clinical study reports, but strict schedules and inspirational project management can only...

Simply does it 01 September, 2020 In recent years, Sanofi has emphasised the importance of direct-to-patient trial supply in laying the groundwork for a more patient-centric clinical research model. Even so,...

In good form 01 September, 2020 With many Covid-19 patients too ill to make their own decisions, treatment data needed urgently and human challenge trials being mooted as a possible way to expedite the development of...

Assistance, acceleration and augmentation 01 September, 2020 AI is set to play a significant role in regulatory and medical writing in the very near future. Dr Barry Drees of Trilogy Writing & Consulting, using his more than 30 years of...

There and back again 01 September, 2020 As perilous as the journey might get, unused investigational products need to come home. Kevin Crawford, head of clinical operations at Tenax Therapeutics, has made drug reconciliation...

This information may be suitable 01 September, 2020 E-labelling promises many benefits for clinical trials, from encouraging regulatory buy-in to enhancing supply chain planning, yet it has not gained the traction that some might like...

Alive and well 01 September, 2020 Emerging stem cell and gene therapies provide unique challenges in a number of areas, including vendor selection and procurement. Emma Green speaks to Jacqueline Barry, chief...

Hand in hand 01 September, 2020 Clinical supply teams work hard to ensure the correct amount of medication is available where and when patients need it. Too little leads to trial delays, while too much...

Tech injection 31 August, 2020 Technology is having a huge impact across all industries, and pharma must keep pace to avoid being left behind. Digitisation offers huge potential for improving patient...

Central to success 31 January, 2020 There is increasing emphasis on the importance of patient-centricity within clinical trials, including encouragement from the FDA to incorporate the patient voice through the...

Lay summaries and writing for patients 31 January, 2020 Lisa Chamberlain James of Trilogy Writing & Consulting and Trishna Bharadia, patient
engagement consultant, examine the trend for increasing and more transparent...

No clear path 31 January, 2020 Driven by ethical considerations and the aim to gain an edge within drug approval, comparator use is growing steadily in clinical trials. However, implementation is by no...

All on file 31 January, 2020 Given the new EMA guidelines put in place to assist sponsors and investigators with clinical trial master file (TMF) requirements, it’s more important than ever to work closely...

All things considered 31 January, 2020 Every clinical trial needs not just the investigational product but a host of ancillary supplies, ranging from laboratory equipment to the paper required for audit trails. Kim Thomas...

The mind leading the blind 31 January, 2020 Interactive response technology (IRT) systems are crucial to the efficient management of clinical trials. The medium has evolved from a telephone-based interface to one based...

Stamp of approval 31 January, 2020 For years, clinical trials have been stymied by confusing regulations and high levels of patient drop-out, all of which wastes money and prevents drugs from getting to the people who...

The cold war 31 January, 2020 Cold-chain shipping involves navigating a number of challenges to prevent product wastage. Eva-Lotta Persson, MSc/CSCP clinical supply chain lead, AstraZeneca R&D Mölndal, speaks to...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.